Melanoma Clinical Trials in North Carolina

Showing 281-300 of 302 trials

A Study for the Treatment of Unresectable Stage III or Metastatic Stage IV Melanoma

NCT00281541

A study with YM155 for the treatment of unresectable stage III or metastatic stage IV melanoma.

Astellas Pharma Inc29 participantsStarted Nov 2005

Tuscon, Arizona, United States • Little Rock, Arkansas, United States • Aurora, Colorado, United States +6 more locations

COMPLETEDPhase 341 miles

Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

NCT00003647

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Injecting allovectin-7 into a person's melanoma cells may make the body build an immune response that will kill tumor cells. PURPOSE: Randomized phase III trial to compare the effectiveness of dacarbazine with or without immunotherapy in treating patients who have stage III or stage IV melanoma.

Stage IV MelanomaStage III MelanomaRecurrent Melanoma

VicalStarted Jul 1998

Little Rock, Arkansas, United States • Bakersfield, California, United States • Encinitas, California, United States +41 more locations

A Study for the Treatment of Unresectable Stage III or Metastatic Stage IV Melanoma

Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

Melanoma Trials in Other Cities

CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy

Study of CP-675,206 in Refractory Melanoma

Phase II Trial of Allovectin-7® for Metastatic Melanoma

Long-term Data Collection for Subjects in MDX-010 Studies

Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma

S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma

S9804: Vinorelbine in Treating Patients With Stage IV Melanoma

A Study of Volociximab in Metastatic Melanoma

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

CP-675,206 In Patients With Advanced Melanoma

Trial of Dacarbazine With or Without Genasense in Advanced Melanoma

Study of XL281 in Adults With Solid Tumors

Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma

A Safety and Efficacy Study of Intravenous 131I-TM601 in Adult Patients With Malignant Melanoma

Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma

Safety, Immune and Tumor Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma

Temozolomide Plus Bevacizumab in Patients With Metastatic Melanoma Involving the Central Nervous System

Other Conditions in North Carolina